The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness

Clin Cancer Res. 2005 May 15;11(10):3601-3. doi: 10.1158/1078-0432.CCR-05-0475.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Antigens, Neoplasm / genetics*
  • Antigens, Neoplasm / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases / genetics*
  • Carbonic Anhydrases / pharmacology
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / immunology*
  • Humans
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / immunology*
  • Patient Selection
  • Prognosis
  • Treatment Outcome

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Interleukin-2
  • CA9 protein, human
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases